[go: up one dir, main page]

PL3229780T3 - Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka - Google Patents

Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka

Info

Publication number
PL3229780T3
PL3229780T3 PL15823780T PL15823780T PL3229780T3 PL 3229780 T3 PL3229780 T3 PL 3229780T3 PL 15823780 T PL15823780 T PL 15823780T PL 15823780 T PL15823780 T PL 15823780T PL 3229780 T3 PL3229780 T3 PL 3229780T3
Authority
PL
Poland
Prior art keywords
treatment
dry eye
eye syndrome
ophthalmic compositions
ophthalmic
Prior art date
Application number
PL15823780T
Other languages
English (en)
Inventor
Lucia Gelsomino
Original Assignee
Alfa Intes Ind Terapeutica Splendore S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Intes Ind Terapeutica Splendore S R L filed Critical Alfa Intes Ind Terapeutica Splendore S R L
Publication of PL3229780T3 publication Critical patent/PL3229780T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15823780T 2014-12-12 2015-12-11 Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka PL3229780T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20142126 2014-12-12
EP15823780.0A EP3229780B1 (en) 2014-12-12 2015-12-11 Ophthalmic compositions for use in the treatment of the dry eye syndrome
PCT/IB2015/059533 WO2016092513A1 (en) 2014-12-12 2015-12-11 Ophthalmic compositions for use in the treatment of the dry eye syndrome

Publications (1)

Publication Number Publication Date
PL3229780T3 true PL3229780T3 (pl) 2019-05-31

Family

ID=52463050

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15823780T PL3229780T3 (pl) 2014-12-12 2015-12-11 Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka

Country Status (7)

Country Link
EP (1) EP3229780B1 (pl)
DK (1) DK3229780T3 (pl)
ES (1) ES2712849T3 (pl)
PL (1) PL3229780T3 (pl)
PT (1) PT3229780T (pl)
TR (1) TR201819920T4 (pl)
WO (1) WO2016092513A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020008046A2 (pt) * 2017-11-21 2020-10-27 Axerovision, Inc. composições e métodos de uso para tratamento de inflamação anormal em glândulas secretoras perioculares ou na superfície ocular
US11759472B2 (en) 2017-11-21 2023-09-19 Cs Pharmaceuticals Limited Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
IT201900023142A1 (it) * 2019-12-05 2021-06-05 Sifi Spa Composizione topica oculare contenente metaboliti della fermentazione di lactobacillus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1546469A (fr) * 1965-09-07 1968-11-22 Merck & Co Inc Stérilisation de médicaments solides
GB1386864A (en) 1972-02-11 1975-03-12 Avicon Inc Micro-crystalline collage-containing pharmaceutical compositions useful for topical applications
JP2945993B2 (ja) * 1989-12-05 1999-09-06 武田薬品工業株式会社 外用剤
ITRM20010438A1 (it) 2001-07-23 2003-01-23 Farmigea Spa Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco.
US20050196370A1 (en) 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
WO2006073786A2 (en) 2004-12-30 2006-07-13 Bausch & Lomb Incorporated Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy

Also Published As

Publication number Publication date
DK3229780T3 (en) 2019-03-18
EP3229780B1 (en) 2018-11-28
WO2016092513A1 (en) 2016-06-16
PT3229780T (pt) 2019-02-27
EP3229780A1 (en) 2017-10-18
TR201819920T4 (tr) 2019-01-21
ES2712849T3 (es) 2019-05-16

Similar Documents

Publication Publication Date Title
GB2548873B (en) Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
HK1254338A1 (zh) 儲存穩定的組合物及治療眼睛屈光不正的方法
SG10201707617VA (en) Ophthalmic composition
IL246791A0 (en) Compositions and methods for treating eye diseases
EP3213723A4 (en) Device for treating dry eye syndrome and strengthening eyesight
EP3190886C0 (en) COMPOSITIONS FOR USE IN THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME
IL251904B (en) Epilimod for use in the treatment of melanoma
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
PL3145511T3 (pl) Kompozycja do leczenia oka
HUE039750T2 (hu) Hidroxi-buspiron mozgászavarok kezelésére
IL246855A0 (en) Materials for use in the treatment of retinitis
HK1225994A1 (zh) 用於治療過敏性病症的組合物
LT3110425T (lt) Nelaki oftalmologinė kompozicija, ypač sausų akių sindromui gydyti
PL3229780T3 (pl) Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka
HK1217913A1 (zh) 阿地米屈在治療上皮功能障礙中的用途
HUE066511T2 (hu) Készítmények hunter-szindróma kezelésére
ZA201703701B (en) Ophthalmic composition
IL251590A0 (en) Ophthalmic preparations
GB201513543D0 (en) Compositions for use in the treatment of diabetes
ZA201408464B (en) Composition for the use in treatment of asthma
GB201413538D0 (en) Ophthalmic compositions and uses thereof
GB201404391D0 (en) Novel compositions having use in therapy